Smart and selective cancer-killing peptides with cell penetrating sequence and dual-targeting mechanism

Key Words:DRUG-DELIVERY; NANOPARTICLES; STRATEGIES; APOPTOSIS; RELEASE; DOXORUBICIN; RECEPTOR; SYSTEMS; DESIGN; ASSAY

Abstract:A series of amphiphilic peptides with sequence of Ac-RGDGPLGLAGI(3)GRn-NH2 (n=4, 6, 8) have been designed for the aim of selective cancer-killing. These molecules have four functional segments, the integrin-binding segment of RGD, the enzyme-cleavable segment of PLGLA, the hydrophobic segment of I-3, and the cell membrane-penetrating segment of octa-arginine. Among them, the peptide with n=8 (RR-22) turns out to be a 'smart' molecule with high efficiency in killing cancer cells and negligible cytotoxicity to normal cells. The concentration causing 50% cancer cell growth inhibition (IC50) is 50 mu M for HeLa, 41 mu M for Hpeg2, and 44 mu M for A549, respectively. The high cancer-killing selectivity is ascribed to the dual cancer-targeting function, that is, the specific recognition and binding of RGD segment to cancer membranes and the cleavage of PLGLA segment by the cancer-overexpressed matrix metalloproteinase-7 (MMP7). This study illustrates an effective strategy for designing smart therapeutic molecules with both selectivity and targeting ability.

Volume:586

Issue:

Translation or Not:no